Search for chemical structures by a sketch :1,4-Dioxa-8-azaspiro[4.5]decane

About 1,4-Dioxa-8-azaspiro[4.5]decane, If you have any questions, you can contact Baska, F; Sipos, A; Orfi, Z; Nemes, Z; Dobos, J; Szantai-Kis, C; Szabo, E; Szenasi, G; Dezsi, L; Hamar, P; Cserepes, MT; Tovari, J; Garamvolgyi, R; Kreko, M; Orfi, L or concate me.. Recommanded Product: 177-11-7

Product Details of 177-11-7. I found the field of Pharmacology & Pharmacy very interesting. Saw the article Discovery and development of extreme selective inhibitors of the ITD and D835Y mutant FLT3 kinases published in 2019, Reprint Addresses Orfi, L (corresponding author), Semmelweis Univ, Dept Pharmaceut Chem, Hogyes Endre U 9, H-1085 Budapest, Hungary.. The CAS is 177-11-7. Through research, I have a further understanding and discovery of 1,4-Dioxa-8-azaspiro[4.5]decane.

Aberrant activation of FMS-like tyrosine receptor kinase 3 (FLT3) is implicated in the pathogenesis of acute myeloid leukemia (AML) in 20-30% of patients. In this study we identified a highly selective (phenylethenyl)quinazoline compound family as novel potent inhibitors of the FLT3-ITD and FLT3-D835Y kinases. Their prominent effects were confirmed by biochemical and cellular proliferation assays followed by mice xenograft studies. Our modelling experiments and the chemical structures of the compounds predict the possibility of covalent inhibition. The most effective compounds triggered apoptosis in FLT3-ITD AML cells but had either weak or no effect in FLT3-independent leukemic and non-leukemic cell lines. Our results strongly suggest that our compounds may become therapeutics in relapsing and refractory AML disease harboring various ITD and tyrosine kinase domain mutations, by their ability to overcome drug resistance. (C) 2019 Elsevier Masson SAS. All rights reserved.

About 1,4-Dioxa-8-azaspiro[4.5]decane, If you have any questions, you can contact Baska, F; Sipos, A; Orfi, Z; Nemes, Z; Dobos, J; Szantai-Kis, C; Szabo, E; Szenasi, G; Dezsi, L; Hamar, P; Cserepes, MT; Tovari, J; Garamvolgyi, R; Kreko, M; Orfi, L or concate me.. Recommanded Product: 177-11-7

Reference:
Piperidine – Wikipedia,
Piperidine | C5H7510N – PubChem

 

Why Are Children Getting Addicted To 177-11-7

About 1,4-Dioxa-8-azaspiro[4.5]decane, If you have any questions, you can contact Yu, WL; Luo, YC; Yan, L; Liu, D; Wang, ZY; Xu, PF or concate me.. COA of Formula: C7H13NO2

Recommanded Product: 177-11-7. In 2019 ANGEW CHEM INT EDIT published article about VISIBLE-LIGHT IRRADIATION; ORGANIC-SYNTHESIS; EVOLUTION; HYDROSILYLATION; ACTIVATION; WATER; FUNCTIONALIZATION; ALKYLATION; ALCOHOLS; OLEFINS in [Yu, Wan-Lei; Luo, Yong-Chun; Yan, Lei; Liu, Dan; Wang, Zhu-Yin; Xu, Peng-Fei] Lanzhou Univ, Coll Chem & Chem Engn, State Key Lab Appl Organ Chem, Lanzhou 730000, Gansu, Peoples R China in 2019, Cited 73. The Name is 1,4-Dioxa-8-azaspiro[4.5]decane. Through research, I have a further understanding and discovery of 177-11-7.

A synergistic catalytic method combining photoredox catalysis, hydrogen-atom transfer, and proton-reduction catalysis for the dehydrogenative silylation of alkenes was developed. With this approach, a highly concise route to substituted allylsilanes has been achieved under very mild reaction conditions without using oxidants. This transformation features good to excellent yields, operational simplicity, and high atom economy. Based on control experiments, a possible reaction mechanism is proposed.

About 1,4-Dioxa-8-azaspiro[4.5]decane, If you have any questions, you can contact Yu, WL; Luo, YC; Yan, L; Liu, D; Wang, ZY; Xu, PF or concate me.. COA of Formula: C7H13NO2

Reference:
Piperidine – Wikipedia,
Piperidine | C5H7510N – PubChem

 

Chemical Properties and Facts of 177-11-7

About 1,4-Dioxa-8-azaspiro[4.5]decane, If you have any questions, you can contact Kopruluoglu, C; Dejmek, M; Sala, M; Ajani, H; Hrebabecky, H; Fanfrlik, J; Jorda, R; Dracinsky, M; Prochazkova, E; Sacha, P; Krystof, V; Hobza, P; Lepsik, M; Nencka, R or concate me.. Quality Control of 1,4-Dioxa-8-azaspiro[4.5]decane

Kopruluoglu, C; Dejmek, M; Sala, M; Ajani, H; Hrebabecky, H; Fanfrlik, J; Jorda, R; Dracinsky, M; Prochazkova, E; Sacha, P; Krystof, V; Hobza, P; Lepsik, M; Nencka, R in [Kopruluoglu, Cemal; Dejmek, Milan; Sala, Michal; Ajani, Haresh; Hrebabecky, Hubert; Fanfrlik, Jindrich; Dracinsky, Martin; Prochazkova, Eliska; Sacha, Pavel; Hobza, Pavel; Lepsik, Martin; Nencka, Radim] Czech Acad Sci, Inst Organ Chem & Biochem, Flemingovo Nam 2, Prague 16610 6, Czech Republic; [Kopruluoglu, Cemal; Ajani, Haresh; Hobza, Pavel] Palacky Univ, Reg Ctr Adv Technol & Mat, Dept Phys Chem, Olomouc, Czech Republic; [Jorda, Radek; Krystof, Vladimir] Palacky Univ, Fac Sci, Lab Growth Regulators, Olomouc, Czech Republic; [Jorda, Radek; Krystof, Vladimir] Czech Acad Sci, Inst Expt Bot, Olomouc, Czech Republic published Optimization of norbornyl-based carbocyclic nucleoside analogs as cyclin-dependent kinase 2 inhibitors in 2020, Cited 45. Recommanded Product: 1,4-Dioxa-8-azaspiro[4.5]decane. The Name is 1,4-Dioxa-8-azaspiro[4.5]decane. Through research, I have a further understanding and discovery of 177-11-7.

We report on the discovery of norbornyl moiety as a novel structural motif for cyclin-dependent kinase 2 (CDK2) inhibitors which was identified by screening a carbocyclic nucleoside analogue library. Three micromolar hits were expanded by the use of medicinal chemistry methods into a series of 16 novel compounds. They had prevailingly micromolar activities against CDK2 and the best compound of the series attained IC(50)of 190 nM. The binding modes were explored in molecular details by modeling and docking. Quantum mechanics-based scoring was used to rationalize the affinities. In conclusion, the discovered 9-hydroxymethylnorbornyl moiety was shown by joint experimental-theoretical efforts to be able to serve as a novel substituent for CDK2 inhibitors. This finding opens door to the exploration of chemical space towards more effective derivatives targeting this important class of protein kinases.

About 1,4-Dioxa-8-azaspiro[4.5]decane, If you have any questions, you can contact Kopruluoglu, C; Dejmek, M; Sala, M; Ajani, H; Hrebabecky, H; Fanfrlik, J; Jorda, R; Dracinsky, M; Prochazkova, E; Sacha, P; Krystof, V; Hobza, P; Lepsik, M; Nencka, R or concate me.. Quality Control of 1,4-Dioxa-8-azaspiro[4.5]decane

Reference:
Piperidine – Wikipedia,
Piperidine | C5H7510N – PubChem

 

Chemical Research in C7H13NO2

COA of Formula: C7H13NO2. About 1,4-Dioxa-8-azaspiro[4.5]decane, If you have any questions, you can contact Flood, DT; Asai, S; Zhang, XJ; Wang, J; Yoon, L; Adams, ZC; Dillingham, BC; Sanchez, BB; Vantourout, JC; Flanagan, ME; Piotrowsld, DW; Richardson, P; Green, SA; Shenvi, RA; Chen, JS; Baran, PS; Dawson, PE or concate me.

In 2019 J AM CHEM SOC published article about GREEN-I; SELECTION; MUTATION; DAMAGE in [Flood, Dillon T.; Asai, Shota; Zhang, Xuejing; Wang, Jie; Yoon, Leonard; Adams, Zoe C.; Dillingham, Blythe C.; Vantourout, Julien C.; Green, Samantha A.; Shenvi, Ryan A.; Baran, Phil S.; Dawson, Philip E.] Scripps Res, Dept Chem, 10550 North Torrey Pines Rd, La Jolla, CA 92037 USA; [Zhang, Xuejing] Sun Yat Sen Univ, Sch Pharmaceut Sci, Inst Drug Synth & Pharmaceut Proc, Guangzhou 510006, Guangdong, Peoples R China; [Flanagan, Mark E.; Piotrowsld, David W.] Pfizer Med Chem, Eastern Point Rd, Groton, CT 06340 USA; [Richardson, Paul] Pfizer Med Chem, 10578 Sci Ctr Dr, San Diego, CA 92121 USA; [Sanchez, Brittany B.; Chen, Jason S.] Scripps Res, Automated Synth Facil, 10550 North Torrey Pines Rd, La Jolla, CA 92037 USA in 2019, Cited 46. The Name is 1,4-Dioxa-8-azaspiro[4.5]decane. Through research, I have a further understanding and discovery of 177-11-7. COA of Formula: C7H13NO2

DNA Encoded Libraries have proven immensely powerful tools for lead identification. The ability to screen billions of compounds at once has spurred increasing interest in DEL development and utilization. Although DEL provides access to libraries of unprecedented size and diversity, the idiosyncratic and hydrophilic nature of the DNA tag severely limits the scope of applicable chemistries. It is known that biomacromolecules can be reversibly, noncovalently adsorbed and eluted from solid supports, and this phenomenon has been utilized to perform synthetic modification of biomolecules in a strategy we have described as reversible adsorption to solid support (RASS). Herein, we present the adaptation of RASS for a DEL setting, which allows reactions to be performed in organic solvents at near anhydrous conditions opening previously inaccessible chemical reactivities to DEL. The RASS approach enabled the rapid development of C(sp(2))-C(sp(3)) decarboxylative cross couplings with broad substrate scope, an electrochemical amination (the first electrochemical synthetic transformation performed in a DEL context), and improved reductive amination conditions. The utility of these reactions was demonstrated through a DEL-rehearsal in which all newly developed chemistries were orchestrated to afford a compound rich in diverse skeletal linkages. We believe that RASS will offer expedient access to new DEL reactivities, expanded chemical space, and ultimately more drug-like libraries.

COA of Formula: C7H13NO2. About 1,4-Dioxa-8-azaspiro[4.5]decane, If you have any questions, you can contact Flood, DT; Asai, S; Zhang, XJ; Wang, J; Yoon, L; Adams, ZC; Dillingham, BC; Sanchez, BB; Vantourout, JC; Flanagan, ME; Piotrowsld, DW; Richardson, P; Green, SA; Shenvi, RA; Chen, JS; Baran, PS; Dawson, PE or concate me.

Reference:
Piperidine – Wikipedia,
Piperidine | C5H7510N – PubChem

 

What about chemistry interests you the most C7H13NO2

About 1,4-Dioxa-8-azaspiro[4.5]decane, If you have any questions, you can contact Xu, RR; Wang, K; Liu, HY; Tang, WJ; Sun, HM; Xue, D; Xiao, JL; Wang, C or concate me.. HPLC of Formula: C7H13NO2

An article Anti-Markovnikov Hydroamination of Racemic Allylic Alcohols to Access Chiral gamma-Amino Alcohols WOS:000573540200001 published article about CATALYZED ASYMMETRIC HYDROGENATION; METHODOLOGY COOPERATIVE CATALYSIS; COMPLEX RUPHOX-RU; C-H AMINATION; BORROWING HYDROGEN; ENANTIOSELECTIVE SYNTHESIS; DIASTEREOSELECTIVE SYNTHESIS; SECONDARY ALCOHOLS; N-ALKYLATION; KETONES in [Xu, Ruirui; Wang, Kun; Liu, Haoying; Tang, Weijun; Sun, Huaming; Xue, Dong; Wang, Chao] Shaanxi Normal Univ, Sch Chem & Chem Engn, Minist Educ, Key Lab Appl Surface & Colloid Chem, Xian 710062, Peoples R China; [Xiao, Jianliang] Univ Liverpool, Dept Chem, Liverpool L69 7ZD, Merseyside, England in 2020, Cited 129. The Name is 1,4-Dioxa-8-azaspiro[4.5]decane. Through research, I have a further understanding and discovery of 177-11-7. SDS of cas: 177-11-7

A ruthenium-catalyzed formal anti-Markovnikov hydroamination of allylic alcohols for the synthesis of chiral gamma-amino alcohols is presented. Proceeding via an asymmetric hydrogen-borrowing process, the catalysis allows racemic secondary allylic alcohols to react with various amines, affording enantiomerically enriched chiral gamma-amino alcohols with broad substrate scope and excellent enantioselectivities (68 examples, up to >99 %ee).

About 1,4-Dioxa-8-azaspiro[4.5]decane, If you have any questions, you can contact Xu, RR; Wang, K; Liu, HY; Tang, WJ; Sun, HM; Xue, D; Xiao, JL; Wang, C or concate me.. HPLC of Formula: C7H13NO2

Reference:
Piperidine – Wikipedia,
Piperidine | C5H7510N – PubChem

 

The Shocking Revelation of 1,4-Dioxa-8-azaspiro[4.5]decane

Application In Synthesis of 1,4-Dioxa-8-azaspiro[4.5]decane. About 1,4-Dioxa-8-azaspiro[4.5]decane, If you have any questions, you can contact Baska, F; Sipos, A; Orfi, Z; Nemes, Z; Dobos, J; Szantai-Kis, C; Szabo, E; Szenasi, G; Dezsi, L; Hamar, P; Cserepes, MT; Tovari, J; Garamvolgyi, R; Kreko, M; Orfi, L or concate me.

In 2019 EUR J MED CHEM published article about ACUTE MYELOID-LEUKEMIA; RISK MYELODYSPLASTIC SYNDROME; ACUTE MYELOGENOUS LEUKEMIA; TYROSINE KINASE; ACTIVATING MUTATION; TANDEM DUPLICATION; WILD-TYPE; IN-VITRO; PHASE-I; RECEPTOR in [Baska, Ferenc; Sipos, Anna; Nemes, Zoltan; Dobos, Judit; Szantai-Kis, Csaba; Garamvolgyi, Rita; Orfi, Laszlo] Vichem Chem Res Ltd, H-1022 Budapest, Hungary; [Orfi, Zoltan] Max Planck Inst Biochem, Dept Mol Biol, D-82152 Martinsried, Germany; [Szabo, Eszter] Semmelweis Univ, Dept Paediat 1, H-1083 Budapest, Hungary; [Szenasi, Gabor; Dezsi, Laszlo; Hamar, Peter] Semmelweis Univ, Inst Pathophysiol, H-1089 Budapest, Hungary; [Dezsi, Laszlo] Semmelweis Univ, Nanomed Res & Educ Ctr, H-1089 Budapest, Hungary; [Cserepes, Mihaly T.; Tovari, Jozsef] Natl Inst Oncol, Dept Expt Pharmacol, H-1122 Budapest, Hungary; [Kreko, Marcell; Orfi, Laszlo] Semmelweis Univ, Dept Pharmaceut Chem, Hogyes Endre U 9, H-1085 Budapest, Hungary; [Orfi, Laszlo] Drug Res Co, Batthyany U 92, H-1161 Budapest, Hungary in 2019, Cited 62. The Name is 1,4-Dioxa-8-azaspiro[4.5]decane. Through research, I have a further understanding and discovery of 177-11-7. Application In Synthesis of 1,4-Dioxa-8-azaspiro[4.5]decane

Aberrant activation of FMS-like tyrosine receptor kinase 3 (FLT3) is implicated in the pathogenesis of acute myeloid leukemia (AML) in 20-30% of patients. In this study we identified a highly selective (phenylethenyl)quinazoline compound family as novel potent inhibitors of the FLT3-ITD and FLT3-D835Y kinases. Their prominent effects were confirmed by biochemical and cellular proliferation assays followed by mice xenograft studies. Our modelling experiments and the chemical structures of the compounds predict the possibility of covalent inhibition. The most effective compounds triggered apoptosis in FLT3-ITD AML cells but had either weak or no effect in FLT3-independent leukemic and non-leukemic cell lines. Our results strongly suggest that our compounds may become therapeutics in relapsing and refractory AML disease harboring various ITD and tyrosine kinase domain mutations, by their ability to overcome drug resistance. (C) 2019 Elsevier Masson SAS. All rights reserved.

Application In Synthesis of 1,4-Dioxa-8-azaspiro[4.5]decane. About 1,4-Dioxa-8-azaspiro[4.5]decane, If you have any questions, you can contact Baska, F; Sipos, A; Orfi, Z; Nemes, Z; Dobos, J; Szantai-Kis, C; Szabo, E; Szenasi, G; Dezsi, L; Hamar, P; Cserepes, MT; Tovari, J; Garamvolgyi, R; Kreko, M; Orfi, L or concate me.

Reference:
Piperidine – Wikipedia,
Piperidine | C5H7510N – PubChem

 

Simple exploration of 1,4-Dioxa-8-azaspiro[4.5]decane

About 1,4-Dioxa-8-azaspiro[4.5]decane, If you have any questions, you can contact Tang, SY; Liu, Y; Li, LJ; Ren, XH; Li, J; Yang, GY; Li, H; Yuan, BX or concate me.. Recommanded Product: 1,4-Dioxa-8-azaspiro[4.5]decane

Name: 1,4-Dioxa-8-azaspiro[4.5]decane. Recently I am researching about C-H; OXIDATION; SULFENAMIDES; THIOLS; WATER; STRATEGIES; AMINES; ALKYL; BOND, Saw an article supported by the National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [21801229, 21502174]. Published in ROYAL SOC CHEMISTRY in CAMBRIDGE ,Authors: Tang, SY; Liu, Y; Li, LJ; Ren, XH; Li, J; Yang, GY; Li, H; Yuan, BX. The CAS is 177-11-7. Through research, I have a further understanding and discovery of 1,4-Dioxa-8-azaspiro[4.5]decane

A practical and scalable electrochemical oxidation of S-H and N-H was developed. This oxidant-and catalyst-free electrochemical process enables S-N bond formation with inexpensive nickel electrodes in an undivided cell. This procedure exhibits broad substrate scopes and good functional-group compatibility. A 50 g scale oxidative coupling augurs well for industrial applications.

About 1,4-Dioxa-8-azaspiro[4.5]decane, If you have any questions, you can contact Tang, SY; Liu, Y; Li, LJ; Ren, XH; Li, J; Yang, GY; Li, H; Yuan, BX or concate me.. Recommanded Product: 1,4-Dioxa-8-azaspiro[4.5]decane

Reference:
Piperidine – Wikipedia,
Piperidine | C5H7510N – PubChem

 

The Best Chemistry compound:177-11-7

About 1,4-Dioxa-8-azaspiro[4.5]decane, If you have any questions, you can contact Kuzey, NG; Ozgur, M; Cemaloglu, R; Asmafiliz, N; Kilic, Z; Acik, L; Aydin, B; Hokelek, T or concate me.. Formula: C7H13NO2

In 2020 J MOL STRUCT published article about PHOSPHORUS-NITROGEN COMPOUNDS; DNA INTERACTIONS; STRUCTURAL INVESTIGATIONS; CYTOTOXIC ACTIVITIES; PHOSPHAZENES; DERIVATIVES; SPIRO in [Kuzey, Nur Guven; Ozgur, Mehtap; Cemaloglu, Resit; Asmafiliz, Nuran; Kilic, Zeynel] Ankara Univ, Dept Chem, TR-06100 Ankara, Turkey; [Acik, Leyla; Aydin, Betul] Gazi Univ, Dept Biol, TR-06500 Ankara, Turkey; [Hokelek, Tuncer] Hacettepe Univ, Dept Phys, TR-06800 Ankara, Turkey in 2020, Cited 40. The Name is 1,4-Dioxa-8-azaspiro[4.5]decane. Through research, I have a further understanding and discovery of 177-11-7. Category: piperidines

The N/N donor-type bromobenzyldiamines (1-3) were successively prepared by reduction of Schiff bases formed as a result of condensation reactions of 4-bromobenzaldehyde with aliphatic diamines. The Cl exchange reactions of hexachlorocyclotriphosphazene (HCCP; trimer; N3P3Cl6; 4) with the bidentate ligands (1-3) produced the new monospiro- (5-7) and dispirocyclotriphosphazenes (8-13) containing 4-bromo-benzyl pendant arm(s). The tetrachloro phosphazenes (5-7) were reacted with pyrrolidine, tetra-1,4-dioxa-8-azaspiro [4.5]decane (DASD) and piperidine to give the tetraamino substituted mono-spirophosphazenes (5a-7c). The spectral analyses of all the phosphazenes were made using appropriate spectroscopic methods; such as FTIR, H-1, C-13, P-31 NMR and ESI-MS. The molecular and crystal structures of 5, 6, 7 and 12 were also determined by X-ray crystallography. On the other hand, the antimicrobial activities of the phosphazenes were evaluated against G (-) and G (+) bacteria and fungi. Some of the tetraaminophosphazenes were found to be very active against several bacteria and fungi. Besides, the interactions of the cyclotriphosphazenes with plasmid DNA were investigated using agarose gel electrophoresis. (C) 2020 Elsevier B.V. All rights reserved.

About 1,4-Dioxa-8-azaspiro[4.5]decane, If you have any questions, you can contact Kuzey, NG; Ozgur, M; Cemaloglu, R; Asmafiliz, N; Kilic, Z; Acik, L; Aydin, B; Hokelek, T or concate me.. Formula: C7H13NO2

Reference:
Piperidine – Wikipedia,
Piperidine | C5H7510N – PubChem

 

Never Underestimate The Influence Of 1,4-Dioxa-8-azaspiro[4.5]decane

Application In Synthesis of 1,4-Dioxa-8-azaspiro[4.5]decane. About 1,4-Dioxa-8-azaspiro[4.5]decane, If you have any questions, you can contact Ghorai, S; Chirke, SS; Xu, WB; Chen, JF; Li, CK or concate me.

Application In Synthesis of 1,4-Dioxa-8-azaspiro[4.5]decane. Recently I am researching about ALLYLATION; LIGANDS; HYDROGENATION; REDUCTION; COMPLEXES; ENANTIO, Saw an article supported by the National Natural Science Foundation of China (NSFC)National Natural Science Foundation of China (NSFC) [21602130]; Shanghai Jiao Tong University. Published in AMER CHEMICAL SOC in WASHINGTON ,Authors: Ghorai, S; Chirke, SS; Xu, WB; Chen, JF; Li, CK. The CAS is 177-11-7. Through research, I have a further understanding and discovery of 1,4-Dioxa-8-azaspiro[4.5]decane

The first earth-abundant cobalt-catalyzed highly branched- and enantioselective allylic amination of racemic branched allylic carbonates bearing alkyl groups with both aromatic and aliphatic amines has been developed. The process allows rapid access of allylic amines in high yields with exclusively branched selectivity and excellent enantioselectivities (normally 99% ee) under mild reaction conditions.

Application In Synthesis of 1,4-Dioxa-8-azaspiro[4.5]decane. About 1,4-Dioxa-8-azaspiro[4.5]decane, If you have any questions, you can contact Ghorai, S; Chirke, SS; Xu, WB; Chen, JF; Li, CK or concate me.

Reference:
Piperidine – Wikipedia,
Piperidine | C5H7510N – PubChem

 

What unique challenges do researchers face in 177-11-7

About 1,4-Dioxa-8-azaspiro[4.5]decane, If you have any questions, you can contact Di Mussi, R; Spadaro, S; Volta, CA; Bartolomeo, N; Trerotoli, P; Staffieri, F; Pisani, L; Iannuzziello, R; Dalfino, L; Murgolo, F; Grasso, S or concate me.. HPLC of Formula: C7H13NO2

Product Details of 177-11-7. Di Mussi, R; Spadaro, S; Volta, CA; Bartolomeo, N; Trerotoli, P; Staffieri, F; Pisani, L; Iannuzziello, R; Dalfino, L; Murgolo, F; Grasso, S in [Di Mussi, Rosa; Pisani, Luigi; Iannuzziello, Rachele; Dalfino, Lidia; Murgolo, Francesco; Grasso, Salvatore] Univ Bari Aldo Moro, Osped Policlin, Dipartimento Emergenza & Trapianti Organo DETO, Sez Anestesiol & Rianimaz, Piazza Giulio Cesare 11, Bari, Italy; [Spadaro, Savino; Volta, Carlo Alberto] Univ Ferrara, Dipartimento Morfol Chirurg & Med Sperimentale, Sez Anestesiol & Terapia Intens Univ, Ferrara, Italy; [Bartolomeo, Nicola; Trerotoli, Paolo] Univ Aldo Moro, Dipartimento Sci Biomed & Oncol Umana, Cattedra Stat Med, Bari, Italy; [Staffieri, Francesco] Univ Bari Aldo Moro, Dipartimento Emergenza & Trapianti Organo DETO, Sez Chirurg Vet, Bari, Italy published Continuous assessment of neuro-ventilatory drive during 12 h of pressure support ventilation in critically ill patients in 2020, Cited 67. The Name is 1,4-Dioxa-8-azaspiro[4.5]decane. Through research, I have a further understanding and discovery of 177-11-7.

Introduction Pressure support ventilation (PSV) should allow spontaneous breathing with a normal neuro-ventilatory drive. Low neuro-ventilatory drive puts the patient at risk of diaphragmatic atrophy while high neuro-ventilatory drive may causes dyspnea and patient self-inflicted lung injury. We continuously assessed for 12 h the electrical activity of the diaphragm (EAdi), a close surrogate of neuro-ventilatory drive, during PSV. Our aim was to document the EAdi trend and the occurrence of periods of Low and/or High neuro-ventilatory drive during clinical application of PSV. Method In 16 critically ill patients ventilated in the PSV mode for clinical reasons, inspiratory peak EAdi peak (EAdi(PEAK)), pressure time product of the trans-diaphragmatic pressure per breath and per minute (PTPDI/b and PTPDI/min, respectively), breathing pattern and major asynchronies were continuously monitored for 12 h (from 8 a.m. to 8 p.m.). We identified breaths with Normal (EAdi(PEAK) 5-15 mu V), Low (EAdi(PEAK) < 5 mu V) and High (EAdi(PEAK) > 15 mu V) neuro-ventilatory drive. Results Within all the analyzed breaths (177.117), the neuro-ventilatory drive, as expressed by the EAdi(PEAK), was Low in 50.116 breath (28%), Normal in 88.419 breaths (50%) and High in 38.582 breaths (22%). The average times spent in Low, Normal and High class were 1.37, 3.67 and 0.55 h, respectively (p < 0.0001), with wide variations among patients. Eleven patients remained in the Low neuro-ventilatory drive class for more than 1 h, median 6.1 [3.9-8.5] h and 6 in the High neuro-ventilatory drive class, median 3.4 [2.2-7.8] h. The asynchrony index was significantly higher in the Low neuro-ventilatory class, mainly because of a higher number of missed efforts. Conclusions We observed wide variations in EAdi amplitude and unevenly distributed Low and High neuro ventilatory drive periods during 12 h of PSV in critically ill patients. Further studies are needed to assess the possible clinical implications of our physiological findings. About 1,4-Dioxa-8-azaspiro[4.5]decane, If you have any questions, you can contact Di Mussi, R; Spadaro, S; Volta, CA; Bartolomeo, N; Trerotoli, P; Staffieri, F; Pisani, L; Iannuzziello, R; Dalfino, L; Murgolo, F; Grasso, S or concate me.. HPLC of Formula: C7H13NO2

Reference:
Piperidine – Wikipedia,
Piperidine | C5H7510N – PubChem